Verve Therapeutics Inc VERV:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:36 PM EDT
36.00quote price arrow down-0.12 (-0.33%)
Volume
1,381
Close
36.12quote price arrow down-1.05 (-2.82%)
Volume
1,104,569
52 week range
10.70 - 78.00
Loading...
  • Open36.37
  • Day High37.21
  • Day Low32.50
  • Prev Close37.17
  • 52 Week High78.00
  • 52 Week High Date09/07/21
  • 52 Week Low10.70
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap2.165B
  • Shares Out59.94M
  • 10 Day Average Volume0.96M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-2.03

KEY STATS

  • Open36.37
  • Day High37.21
  • Day Low32.50
  • Prev Close37.17
  • 52 Week High78.00
  • 52 Week High Date09/07/21
  • 52 Week Low10.70
  • 52 Week Low Date06/16/22
  • Market Cap2.165B
  • Shares Out59.94M
  • 10 Day Average Volume0.96M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-2.03

RATIOS/PROFITABILITY

  • EPS (TTM)-2.58
  • P/E (TTM)-13.98
  • Fwd P/E (NTM)-12.42
  • EBITDA (TTM)-128.113M
  • ROE (TTM)-35.68%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Verve Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Verve Therapeutics, Inc. is a genetic medicines company, developing an approach to the care of cardiovascular disease (CVD) transforming treatment from chronic management to single-course gene editing medicines. The Company’s initial two programs target PCSK9 and ANGPTL3, respectively, genes that regulate levels of blood lipids. Its lead product candidate, VERVE-101, is designed to permanently turn off the PCSK9 gene in the liver. Reduction of PCSK9 protein in the blood...
Burt Adelman M.D.
Independent Chairman of the Board
Sekar Kathiresan M.D.
Chief Executive Officer, Director
Andrew Ashe J.D.
President, Chief Operating Officer
Allison Dorval CPA
Chief Financial Officer
Address
500 Technology Square
Cambridge, MA
02139
United States

Top Peers

SYMBOLLASTCHG%CHG
CLDX
Celldex Therapeutics Inc
36.73-0.59-1.58%
IBRX
Immunitybio Inc
4.31-0.24-5.27%
AXSM
Axsome Therapeutics Inc
43.13-1.12-2.53%
SANA
Sana Biotechnology Inc
7.58-0.34-4.29%
ISEE
IVERIC bio Inc
12.78-0.38-2.89%